James C. Czirr, Director at GALECTIN THERAPEUTICS INC (GALT), sold 449,588 shares at $5.45 ($2.4M) on 2018-01-25, disclosed to the SEC on 2018-01-29.
Open-market sale of $2.4M GALT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.45 | 205,144 | $1.1M | 45.7% |
| 2 | $5.45 | 205,144 | $1.1M | 45.7% |
| 3 | $5.35 | 39,300 | $210K | 8.6% |
| Total | $5.44 avg | 449,588 | $2.4M | 100% |
| Filing → |
| GALT | SELL | 2022-08-09 | $21K | — | Filing → |
| GALT | SELL | 2021-08-03 | $33K | — | Filing → |
| GALT | SELL | 2021-05-04 | $109K | — | Filing → |